What Fitch Ratings Has to Say About the UK Election
The U.K. general election results are in and it has a few people surprised. Fitch Ratings has commented on the uncertainty that is arising from this situation.
All Work
Chris Lange
Who Wins From Endo’s Opana Getting Pulled From the Market
In an unprecendented move, the U.S. Food and Drug administration (FDA) requested that Endo International remove its Opana ER from the market. Ultimately, the agency held concerns about abuse surrounding the drug.
Cloudera Sinks Despite Beating Q1 Estimates
After the markets closed on Thursday, Cloudera reported its first earnings report as a public company. Shares tumbled early Friday.
FDA Shelves Endo Pharma Amid Opioid Abuse
In an unprecedented move, the FDA has requested that Endo International remove its opioid pain medication from the market. The agency now believes that the benefits of the drug may no longer outweigh its…
Lexicon Pharmaceuticals Rises on Late-Stage Diabetes Trial
Shares of Lexicon Pharmaceuticals saw a hand gain early on Friday after the company reported top-line results from its late-stage trial in type-1 diabetes.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was another flat day for the broad markets with the exception of the Nasdaq which closed at a record high. As for the S&P 500, the only strong sector in Thursday’s session was…
Why the Credit Suisse $165 Target on McDonald’s Could Be Understated
Credit Suisse just issued a report about McDonald's, raising its price target, although the report seems lackluster. However, the firm did note that this could be understated and that the stock could have much…
Inovio Pharmaceuticals Kicks Off Late-Stage HPV Clinical Trial
Inovio Pharmaceuticals shares posted a solid gain on Thursday after the company announced that it was beginning its late-stage trial of its treatment for cervical dysplasia caused by human papillomavirus (HPV).
Valeant Pharmaceuticals Plans to Sell iNova Segment
Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business.
3 Tech Stocks That Destroyed Shareholders During Earnings Season
The summer doldrums are just arriving, and 24/7 Wall Street has picked out a few companies in the tech sector posting some of the largest losses from this past earnings season.
Dell Sinks Despite Posting Solid Earnings Growth in Q1
Dell Technologies reported its fiscal first-quarter financial results before the markets opened on Thursday and shares retreated.
Will Nordstrom Take Itself Private?
Nordstrom watched its shares make a handy gain on Thursday after it was announced that members of the Nordstrom family may be looking to take this company private.
NewLink Genetics Sinks After Regaining Licensing Rights for Its Cancer Treatment
NewLink Genetics shares backed off early on Thursday after the company announced that it had regained the rights to its cancer treatment. Newlink shareholders are obviously not happy after missing out on that sweet…
Is SciClone Pharma Getting Enough in the Buyout?
SciClone Pharmaceuticals saw its shares make a solid gain early on Thursday after it was announced that the company entered into a definitive agreement to be acquired by a consortium of companies.
9 Companies That Destroyed Shareholders This Earnings Season
Although the tailwind of broad earnings growth and favorable would-be policies of the Trump administration have bolstered the markets in general, there are still many major companies that just are not benefiting at all…
Wednesday’s Biggest Winners and Losers in the S&P 500
The broad markets posted some slight gains on Wednesday, but they were fairly muted due to Crude oil prices absolutely plunging. Crude oil dropped to its lowest level since last August, and Oil &…
Novavax Rises Following Successful Mid-Stage Vaccine Trial
Shares of Novavax saw a handy gain on Wednesday after the company announced updated results from its mid-stage trial for the treatment of the respiratory syncytial virus.
Why Argus Sees Apple Rising Another 15%
A few of the Apple bulls argue that the recently announced offerings play to the strengths of Apple's enormous and unmatched installed base, while bears argue that Apple lacks visionary products and is reduced…
Why One Key Analyst Thinks Beverage Stocks Are About to Slow Down
24/7 Wall St. has taken a close look at a recent report from BMO Capital Markets and how it views the beverage industry and where these stocks stand to go from here.
How Carvana Won Big in Its First Post-IPO Earnings
Carvana has reported its first quarterly financial results since the company came public in late April.